134 related articles for article (PubMed ID: 8627052)
41. Immunodiagnostic studies on Onchocerca volvulus and Mansonella perstans infections using a recombinant 33 kDa O. volvulus protein (Ov33).
Tawill SA; Kipp W; Lucius R; Gallin M; Erttmann KD; Büttner DW
Trans R Soc Trop Med Hyg; 1995; 89(1):51-4. PubMed ID: 7747307
[TBL] [Abstract][Full Text] [Related]
42. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
43. Amocarzine investigated as oral onchocercacidal drug in 272 adult male patients from Guatemala. Results from three dose regimens spread over three days.
Zea-Flores G; Beltranena F; Poltera AA; Lopez M; Moran M; Zea-Flores CE; de Ramirez I; Lecaillon JB; Zak F; Palomo M
Trop Med Parasitol; 1991 Sep; 42(3):240-62. PubMed ID: 1801152
[TBL] [Abstract][Full Text] [Related]
44. Onchocerciasis diagnosis and the probability of visual loss in patients with skin snips negative for Onchocerca volvulus microfilariae.
Langham ME; Richardson R
Tropenmed Parasitol; 1981 Sep; 32(3):171-80. PubMed ID: 7345681
[TBL] [Abstract][Full Text] [Related]
45. Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection.
Abd-Elfarag G; Carter JY; Raimon S; Sebit W; Suliman A; Fodjo JNS; Olore PC; Biel KP; Ojok M; Logora MY; Colebunders R
Epileptic Disord; 2020 Jun; 22(3):301-308. PubMed ID: 32540799
[TBL] [Abstract][Full Text] [Related]
46. Onchocerca volvulus: development of a species specific polymerase chain reaction-based assay.
Merriweather A; Unnasch TR
Exp Parasitol; 1996 Jun; 83(1):164-6. PubMed ID: 8654547
[No Abstract] [Full Text] [Related]
47. An evaluation of implanted male Onchocerca gibsoni in mice as a screen for macrofilaricides against Onchocerca volvulus.
Vankan DM; Copeman DB; Novak M
Trop Med Parasitol; 1988 Dec; 39 Suppl 4():472-4. PubMed ID: 3227248
[TBL] [Abstract][Full Text] [Related]
48. Chemokines and cytokines in patients with an occult Onchocerca volvulus infection.
Lechner CJ; Gantin RG; Seeger T; Sarnecka A; Portillo J; Schulz-Key H; Karabou PK; Helling-Giese G; Heuschkel C; Banla M; Soboslay PT
Microbes Infect; 2012 May; 14(5):438-46. PubMed ID: 22202179
[TBL] [Abstract][Full Text] [Related]
49. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
Mbah GE; Ayiseh RB; Cho-Ngwa F
BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
[TBL] [Abstract][Full Text] [Related]
50. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
51. Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador.
Elson LH; Guderian RH; Araujo E; Bradley JE; Days A; Nutman TB
J Infect Dis; 1994 Mar; 169(3):588-94. PubMed ID: 8158031
[TBL] [Abstract][Full Text] [Related]
52. Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay.
Fischer P; Büttner DW; Bamuhiiga J; Williams SA
Am J Trop Med Hyg; 1998 Jun; 58(6):816-20. PubMed ID: 9660471
[TBL] [Abstract][Full Text] [Related]
53. The effect of drug treatment on the pattern of emergence of Onchocerca volvulus microfilariae from skin snips.
Kale OO
J Helminthol; 1981 Jun; 55(2):79-83. PubMed ID: 7264274
[TBL] [Abstract][Full Text] [Related]
54. DNA probe-based classification of Simulium damnosum s. l.-borne and human-derived filarial parasites in the onchocerciasis control program area.
Toe L; Merriweather A; Unnasch TR
Am J Trop Med Hyg; 1994 Nov; 51(5):676-83. PubMed ID: 7985761
[TBL] [Abstract][Full Text] [Related]
55. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
[TBL] [Abstract][Full Text] [Related]
56. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
[TBL] [Abstract][Full Text] [Related]
57. Onchocerca volvulus: genetic diversity of parasite isolates from Sudan.
Higazi TB; Katholi CR; Mahmoud BM; Baraka OZ; Mukhtar MM; Qubati YA; Unnasch TR
Exp Parasitol; 2001 Jan; 97(1):24-34. PubMed ID: 11207111
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.
Awadzi K; Opoku NO; Attah SK; Lazdins-Helds JK; Kuesel AC
Parasit Vectors; 2015 Oct; 8():515. PubMed ID: 26452723
[TBL] [Abstract][Full Text] [Related]
59. Detection of Onchocerca volvulus in Skin Snips by Microscopy and Real-Time Polymerase Chain Reaction: Implications for Monitoring and Evaluation Activities.
Thiele EA; Cama VA; Lakwo T; Mekasha S; Abanyie F; Sleshi M; Kebede A; Cantey PT
Am J Trop Med Hyg; 2016 Apr; 94(4):906-11. PubMed ID: 26880774
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the use of skin scarification and skin biopsies to determine the prevalence and intensity of Onchocerca volvulus infection.
Newell ED
Ann Trop Med Parasitol; 1997 Sep; 91(6):633-42. PubMed ID: 9425366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
